Metraipolis › archive › dc_3dc8fb3579d0

Serum or Plasma Oncostatin M for Predicting Primary Non-Response to Tumor Necrosis Factor-α Antagonist Therapy in Inflammatory Bowel Disease: A Systematic… — Europe PMC PMID:42505684

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42505684
DOI
10.3390/clinpract16070124
License (as archived)
solo-consultazione
Archived
2026-10-18T11:59:50.691Z
SHA-256 of the archived text
7af5d8106dba2a3b55324a8a42e814d56515dc776207b73ead7c477538eeab48
Stable URL of this page
https://metraipolis.com/documento/dc_3dc8fb3579d0

How to cite

Serum or Plasma Oncostatin M for Predicting Primary Non-Response to Tumor Necrosis Factor-α Antagonist Therapy in Inflammatory Bowel Disease: A Systematic… — Europe PMC PMID:42505684 — Europe PMC (en), https://europepmc.org/article/MED/42505684 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3dc8fb3579d0 (Metraipolis archive dc_3dc8fb3579d0, sha256 7af5d8106dba2a3b55324a8a42e814d56515dc776207b73ead7c477538eeab48)
BibTeX
@misc{dc3dc8fb3579d0,
  title = {Serum or Plasma Oncostatin M for Predicting Primary Non-Response to Tumor Necrosis Factor-α Antagonist Therapy in Inflammatory Bowel Disease: A Systematic… — Europe PMC PMID:42505684},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42505684},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3dc8fb3579d0; sha256 7af5d8106dba2a3b55324a8a42e814d56515dc776207b73ead7c477538eeab48},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42505684. Agents can read the archived copy with the MCP tool read_document.